GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (BOM:539871) » Definitions » Gross-Profit-to-Asset %

Thyrocare Technologies (BOM:539871) Gross-Profit-to-Asset % : 79.50% (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Thyrocare Technologies's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₹5,507 Mil. Thyrocare Technologies's average Total Assets over the quarter that ended in Mar. 2025 was ₹6,928 Mil. Therefore, Thyrocare Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 79.50%.


Thyrocare Technologies Gross-Profit-to-Asset % Historical Data

The historical data trend for Thyrocare Technologies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Gross-Profit-to-Asset % Chart

Thyrocare Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.07 72.68 58.60 63.48 74.26

Thyrocare Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.89 69.24 84.66 80.90 79.50

Competitive Comparison of Thyrocare Technologies's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Thyrocare Technologies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Gross-Profit-to-Asset % falls into.


;
;

Thyrocare Technologies Gross-Profit-to-Asset % Calculation

Thyrocare Technologies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2025 )/( (Total Assets (A: Mar. 2024 )+Total Assets (A: Mar. 2025 ))/ count )
=4962.7/( (6438.8+6927.5)/ 2 )
=4962.7/6683.15
=74.26 %

Thyrocare Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=5507.2/( (0+6927.5)/ 1 )
=5507.2/6927.5
=79.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Thyrocare Technologies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies Business Description

Traded in Other Exchanges
Address
D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines